ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120195966A1
SERIAL NO

13360141

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RATIOPHARM GMBH89079 ULM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
SIEVERT, Frank Allmendingen, DE 6 17
STEFAN, Ralph Ebenweiler, DE 19 59

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation